A method for the treatment of tumours and sarcomas
CA 2104576 C · Owner: Amrad Corporation Limited · Inventors: Kannourakis, George
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to the use of leukaemia inhibitory factor and pharmaceutical compositions comprising same in the treatment of undifferentiated tumours and sarcomas in mammals. The present invention is particularly directed to the treatment of Ewing's Sarcoma, Rhabdosarcoma and other sarcomas of connective tissue bones, bladder, kidneys, liver, lungs, parotids or spleen.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 24, 1992 and granted April 15, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 24, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 24, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.